Add-on Acquisition • Life Science

GE Healthcare Acquires Biacore International AB

On August 15, 2006, GE Healthcare acquired life science company Biacore International AB for 390M USD

Acquisition Context
  • This is GE Healthcare’s 2nd transaction in the Life Science sector.
  • This is GE Healthcare’s 8th largest (disclosed) transaction.
  • This is GE Healthcare’s 1st transaction in Sweden.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date August 15, 2006
Target Biacore International AB
Sector Life Science
Buyer(s) GE Healthcare
Deal Type Add-on Acquisition
Deal Value 390M USD

Target Company

Biacore International AB

Uppsala, Sweden
Biacore International AB is a pro­vider of life science tools for pro­tein research.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

GE Healthcare

Westborough, Massachusetts, United States

Category Company
Founded 1994
Sector Medical Products
DESCRIPTION

GE Healthcare, a unit of General Electric Company is a provider of medical technologies and services. GE Healthcare has expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, life sciences, drug discovery, and biopharmaceutical manufacturing technologies. GE Healthcare is based in Westborough, Massachusetts.


Deal Context for Buyer #
Overall 5 of 34
Sector: Life Science 2 of 6
Type: Add-on Acquisition 4 of 29
Country: Sweden 1 of 2
Year: 2006 1 of 1
Size (of disclosed) 8 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-09-29 IDX Systems

Burlington, Vermont, United States

IDX Systems Corp. provides information technology solutions to maximize value in the delivery of healthcare, improve the quality of patient service, enhance medical outcomes, and reduce the costs of care. Our systems are deployed to serve approximately 150,000 physicians and are installed at over 3,400 customer sites, including more than 850 group practices and approximately 370 integrated delivery networks servicing more than 500 hospitals.

Buy $1.2B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-16 Wave Biotech

United States

Wave Biotech is a research-based company that develops and manufactures innovative process equipment for the pharmaceutical and biotechnology industry. Our focus is on developing disposable bioprocess equipment for operations traditionally requiring stainless-steel tanks and piping.

Buy -